Adiponectin, a hormone produced by adipose tissue, has gained recognition for its antiproliferative, proapoptotic, and antiangiogenic properties, making it a potential therapeutic target in the obesity-cancer connection. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.